Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.605 AUD | +0.83% | -0.82% | -15.38% |
Sales 2024 * | 5.47M 3.57M | Sales 2025 * | 21.39M 13.98M | Capitalization | 235M 153M |
---|---|---|---|---|---|
Net income 2024 * | -30M -19.6M | Net income 2025 * | -22M -14.37M | EV / Sales 2024 * | 36.7 x |
Net cash position 2024 * | 34.05M 22.25M | Net cash position 2025 * | 17.16M 11.21M | EV / Sales 2025 * | 10.2 x |
P/E ratio 2024 * |
-7.83
x | P/E ratio 2025 * |
-10.6
x | Employees | 131 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 72.38% |
Latest transcript on 4DMedical Limited
1 day | +0.83% | ||
1 week | -0.82% | ||
Current month | -6.92% | ||
1 month | -1.63% | ||
3 months | -2.42% | ||
6 months | +28.72% | ||
Current year | -15.38% |
Managers | Title | Age | Since |
---|---|---|---|
Andreas Fouras
CEO | Chief Executive Officer | - | 12-11-30 |
Simon Glover
DFI | Director of Finance/CFO | - | 22-07-24 |
Jon Dusting
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Figlin
BRD | Director/Board Member | - | - |
Julian Sutton
BRD | Director/Board Member | - | 17-08-31 |
Director/Board Member | 60 | 23-09-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.605 | +0.83% | 352 556 |
24-04-24 | 0.6 | -1.64% | 160,544 |
24-04-23 | 0.61 | +0.83% | 273,207 |
24-04-22 | 0.605 | -0.82% | 130,806 |
24-04-19 | 0.61 | +1.67% | 451,246 |
Delayed Quote Australian S.E., April 26, 2024 at 02:10 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.38% | 153M | |
+7.71% | 218B | |
+6.25% | 182B | |
+10.60% | 132B | |
+26.73% | 108B | |
-0.30% | 62.51B | |
+15.42% | 52.98B | |
-1.89% | 47.59B | |
-1.91% | 39.96B | |
+11.16% | 39.22B |
- Stock Market
- Equities
- 4DX Stock